News Image

24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy

Provided By GlobeNewswire

Last update: Aug 27, 2025

DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication of a new manuscript in Trends in Cancer (July 2025, Vol. 11, No. 7, https://doi.org/10.1016/j.trecan.2025.04.009) describing the first international conference on activation of oncogenic signaling as a cancer treatment strategy.

Read more at globenewswire.com

LIXTE BIOTECHNOLOGY HOLDINGS

NASDAQ:LIXT (10/24/2025, 8:00:02 PM)

4.33

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more